E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/10/2013 in the Prospect News Bank Loan Daily.

S&P lifts Boston Luxembourg, loans

Standard & Poor's said it raised its long-term corporate credit rating on Boston Luxembourg II Sarl, the parent company of BSN Medical, to B+ from B.

The outlook is stable.

At the same time, the agency raised its issue rating on the senior secured bank facilities issued by LuxDebtCo due in 2019 to BB- from B+. The recovery rating on this instrument remains unchanged at 2, indicating an expectation of substantial (70%-90%) recovery in the event of a payment default.

The ratings were removed from CreditWatch, where they were placed with positive implications on Nov. 26.

S&P said it bases the upgrades primarily on its reassessment of the importance of volatility of earnings for Boston Luxembourg under our new corporate criteria. The agency also takes into account the relative stability of the company's cash flows in the health care equipment sector.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.